Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a

Waters Corporation (WAT) Shares outstanding

Alert me on Shares outstanding

Waters Corporation's shares outstanding at the end of fiscal 2025 was $59.7M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $98.2M. Over the past ten years it has ranged from $59.3M (fiscal 2023) to $83.1M (fiscal 2015); the current reading is higher than 27% of that period. Waters Corporation ranks 18th of 52 Diagnostics & Research companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $59.7M 0.26%
FY2024 $59.6M 0.48%
FY2023 $59.3M (1.76%)
FY2022 $60.3M (2.74%)
FY2021 $62.0M (0.62%)
FY2020 $62.4M (8.44%)
FY2019 $68.2M (12.18%)
FY2018 $77.6M (3.70%)
FY2017 $80.6M (1.00%)
FY2016 $81.4M (2.01%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $98.2M 19.56%
Mar 2026 $82.1M 37.57%
Dec 2025 $59.7M 0.14%
Sep 2025 $59.6M (0.06%)
42 more quarters

Against its own ten years

Low $59.3M High $83.1M
Ten-year median $62.4M
Current reading's percentile 27

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on WAT